Neurovascular Embolization Devices Industry Insights 2025 – Market Forecast for Executives and Planners
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has The Neurovascular Embolization Devices Market Size Shifted, And What Is the Outlook Through 2034?
In recent times, there has been a significant expansion in the size of the neurovascular embolization devices market. It is projected to escalate from $1.32 billion in 2024 to approximately $1.4 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.2%. Factors including a surge in neurovascular diseases, the exponential growth of the elder population, the preference for minimally invasive methods, the enhancement in healthcare facilities, and the rise in healthcare expenses have all contributed to the historical growth.
How Much Will the Neurovascular Embolization Devices Market Be Worth in 2029?
In the coming years, the neurovascular embolization devices market is slated to witness robust growth, set to reach a value of $1.8 billion by 2029, with a CAGR of 6.5%. The projected growth can be ascribed to factors such as the exploration of new applications in emerging markets, a focus on patient-oriented care, increased awareness about neurovascular diseases, technological strides in imaging, and heightened investment in R&D. The forecast period is expected to see key trends such as personalized treatment strategies, incorporation of AI in treatment planning, the introduction of advanced embolic materials, a shift towards outpatient and ambulatory procedures, and the introduction of inventive embolization techniques.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15871&type=smp
Which is the Largest Company in the Neurovascular Embolization Devices Market?
Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc., Penumbra Inc., Asahi Intecc Co Ltd., MicroVention Inc., Balt USA LLC, Imperative Care Inc., InNeuroCo Inc., Acandis GmbH & Co KG, Rapid Medical Ltd., Emboline Inc., InspireMD Inc., QXMedical LLC, Vesalio LLC, EmbolX Inc
What Are the Main Market Drivers in the Neurovascular Embolization Devices Industry?
An increase in the frequency of hemorrhages is anticipated to fuel the growth of the neurovascular embolization devices market. Hemorrhages, which represent unusual, unregulated bleeding within the body or externally from a wound in the skin or mucous membrane, are becoming more prevalent due to a variety of factors. These factors include the graying of the population, a heightened occurrence of hypertension, and the broad deployment of anticoagulant drugs. Neurovascular embolization devices are used in cases of hemorrhagic strokes to block abnormal blood vessels, thus limiting bleeding and safeguarding against additional brain injury. As per King’s College London’s research in February 2024, it is projected that the incidents and fatalities resulting from intracerebral hemorrhage (ICH) – a specific form of hemorrhage, will rise by 59.4% among individuals aged 70 to 95 across the UK by 2050. As a result, the escalating prevalence of hemorrhages contributes to the expansion of the neurovascular embolization devices market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15871&type=smp
How Is the Neurovascular Embolization Devices Market Segments Structured?
The neurovascular embolization devices market covered in this report is segmented –
1) By Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
2) By Treatment: Ischemic Stroke Solution, Hemorrhagic Stroke Solutions
3) By Indication: Brain Aneurysms, Arteriovenous Malformation, Other Indications
4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Embolization Coils: Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
2) By Liquid Embolic Systems: Gluteraldehyde-Based Liquid Embolization, Onyx Liquid Embolic System
3) By Flow Diversion Stents: Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
4) By Aneurysm Clips: Titanium Clips, Stainless Steel Clips
5) By Other Products: Balloons For Embolization, Microcatheters
What Strategic Trends Are Transforming the Neurovascular Embolization Devices Market?
Key players in the neurovascular embolization devices market are prioritizing the advancement of their products, including shield technology, to effectively treat brain aneurysms and to maintain a competitive advantage. Shield Technology is an advanced feature aimed at increasing the efficiency and safety of these devices, thereby improving their overall durability and lifespan. Take for example, the Ireland-based healthcare technology firm Medtronic PLC, which in June 2022 released the fourth-generation flow diverter, the Pipeline Vantage with Shield Technology, in India. It’s enhanced design features augment usability and dependability during endovascular procedures. This device encourages the growth of cells in the inner lining of the blood vessel, acting as a scaffold that facilitates the minimally invasive treatment of aneurysms, minimizing the risk of rupture, and enhancing patient outcomes.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Neurovascular Embolization Devices Market?
North America was the largest region in the neurovascular embolization devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15871
This Report Delivers Insight On:
1. How big is the neurovascular embolization devices market, and how is it changing globally?
2. Who are the major companies in the neurovascular embolization devices market, and how are they performing?
3. What are the key opportunities and risks in the neurovascular embolization devices market right now?
4. Which products or customer segments are growing the most in the neurovascular embolization devices market?
5. What factors are helping or slowing down the growth of the neurovascular embolization devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model